Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-03-01
2011-03-01
Chu, Yong (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S257000, C548S260000, C548S261000
Reexamination Certificate
active
07897625
ABSTRACT:
The invention relates to carbamoylbenzotriazole derivatives of general formula (I), which are defined as cited in the description, to their pharmaceutically applicable salts and to their use as medicaments.
REFERENCES:
patent: 4273860 (1981-06-01), Adin
patent: 6440648 (2002-08-01), Southby et al.
patent: 1164419 (2001-12-01), None
patent: 1164421 (2001-12-01), None
patent: 2282124 (1976-03-01), None
patent: 1505699 (1978-03-01), None
patent: 62039573 (1987-02-01), None
patent: WO 2004/035550 (2004-04-01), None
Croatica Chemica Acta 73(2), pp. 569-574 (2000).
Butula, et. al., Reactions with 1-Benzotriazolecarboxylic Acid Chloride. VIII. Synthesis of N-Hydroxyisocyanate Derivatives, Croatian Chemical Society, vol. 73, No. 2, (2000), pp. 569-574.
Möller Günter
Petry Stefan
Tennagels Norbert
Zoller Gerhard
Barker Michael
Chu Yong
Sanofi-Aventis
Scully , Scott, Murphy & Presser, P.C.
LandOfFree
Carbamoylbenzotriazole derivatives as inhibitors of lipases... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carbamoylbenzotriazole derivatives as inhibitors of lipases..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbamoylbenzotriazole derivatives as inhibitors of lipases... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2761161